CytoDyn Inc. Quarterly report pursuant to Section 13 or 15(d)

Stock Options and Warrants (Tables)

6 Months Ended

Nov. 30, 2019

The following table represents stock option and warrant activity as of and for the

six

months ended

November 30

, 2019:


	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Options and warrants outstanding—May 31, 2019		178,591,849		$	0.71		3.75	$	896,400

Granted		30,756,055			0.36		—		—
Exercised		(30,250,649	)		0.39		—		—
Forfeited/expired/cancelled		(1,640,000	)		0.74		—		—

Options and warrants outstanding — November 30, 2019		177,457,255			0.65		3.67		—

Outstanding exercisable — November 30, 2019		173,178,551		$	0.66		3.56	$	—